SGLT2 Inhibitors

9 registered clinical trials studyying SGLT2 Inhibitors — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	CCTA Evaluation of SGLT2i-related Pericoronary Fat Changes in Non-diabetic ACS Patients Without HF NCT07351643	Shenyang Northern Hospital	Phase 4
Recruiting	Efficacy of SGLT2 Inhibitors in Adults With Sepsis NCT06473844	Hospital Authority, Hong Kong	N/A
Recruiting	Cardiovascular and Renal Endpoints With Flozins - an Observational Prospective Study in CKD HFpEF Patients NCT07237451	Grigore T. Popa University of Medicine and Pharmacy	—
Unknown	Empagliflozin and Red Blood Cell 2,3-biphosphoglycerate Levels NCT06284850	Aristotle University Of Thessaloniki	—
Completed	SGLT2 Inhibitors Between Reno Protective Effects and Impact on Bone and Mineral Disease Among Lupus Nephritis NCT05704088	Mansoura University	Phase 4
Completed	Cardio Renal Effects of SGLT2 Inhibitors Among Lupus Nephritis Patients NCT05748925	Mansoura University	Phase 4
Unknown	SGLT2 Inhibitors and Reducing the Risk of Cancers Among Diabetics , an Observational Study NCT05612269	Ministry of Health, Saudi Arabia	—
Active Not Recruiting	Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B Patients NCT05147090	The University of Hong Kong	Phase 4
Recruiting	Effect of Tofogliflozin on UACR Compared to Metformin Hydrochloride in Diabetic Kidney Disease (TRUTH-DKD) NCT05469659	Shinshu University	Phase 2